Investors & Media

analyst coverage

Firm Analyst
Bank of America Merrill Lynch
Ying Huang
Barclays
Gena Wang
Bernstein
Vincent Chen
BMO Capital Markets
Matthew Luchini
Canaccord Genuity
John Newman
Cantor Fitzgerald
Elemer Piros Ph.D.
Cowen
Chris Shibutani
Evercore ISI
Joshua Schimmer M.D.
Goldman Sachs
Salveen Richter
Guggenheim Partners
Michael Schmidt
J.P. Morgan
Cory Kasimov
Janney
Yun Zhong Ph.D.
Jefferies
Biren Amin
Leerink
Mani Foroohar
Maxim Group
Jason McCarthy Ph.D.
Morgan Stanley
Matthew Harrison
Oppenheimer
Mark Breidenbach
Piper Jaffray & Co
Tyler Van Buren
SunTrust Robinson Humphrey
Edward Nash
Wedbush PacGrowth Life Sciences
David Nierengarten Ph.D.
Wells Fargo
Jim Birchenough
William Blair
Raju Prasad Ph.D.

bluebird bio, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding bluebird bio, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of bluebird bio, Inc. or its management. bluebird bio, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Media Contacts

Jenn Snyder

VP, Corporate Communications

(617) 448-0281

JSnyder@bluebirdbio.com

 

Catherine Falcetti

Senior Director, Corporate Communications

(339) 499-9436

CFalcetti@bluebirdbio.com

 

Investor Contact

Elizabeth Pingpank

Director, Corporate Communications

(617) 914-8736

EPingpank@bluebirdbio.com